Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Nuvation Bio Inc
(NY:
NUVB
)
2.880
+0.080 (+2.86%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nuvation Bio Inc
< Previous
1
2
3
Next >
Biotech’s Role in Addressing the Pancreatic Cancer Emergency
March 14, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:NVX),(NASDAQ:IBRX),(NASDAQ:ACRS),(NYSE:NUVB) EQNX::TICKER_END
Via
FinancialNewsMedia
Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
February 29, 2024
From
Nuvation Bio Inc.
Via
Business Wire
Nuvation Bio Announces Appointment of Dr. Robert Mashal to its Board of Directors
January 08, 2024
From
Nuvation Bio Inc.
Via
Business Wire
Analyst Expectations for Nuvation Bio's Future
March 24, 2023
Via
Benzinga
Where Nuvation Bio Stands With Analysts
March 24, 2023
Via
Benzinga
After FDA Hold, Nuvation Bio Stops NUV-422 Cancer Development Program
August 01, 2022
Via
Benzinga
Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid Tumors
January 08, 2024
From
Nuvation Bio Inc.
Via
Business Wire
Nuvation Bio Announces Departure of Chief Financial Officer
November 13, 2023
From
Nuvation Bio Inc.
Via
Business Wire
Nuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business Update
November 02, 2023
From
Nuvation Bio Inc.
Via
Business Wire
Nuvation Bio And 3 Other Stocks Under $4 Insiders Are Buying
September 22, 2023
The Dow Jones closed lower by more than 300 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Nuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
August 03, 2023
From
Nuvation Bio Inc.
Via
Business Wire
Nuvation Bio Announces Formation of Oncology-Focused Scientific Advisory Board
June 01, 2023
From
Nuvation Bio Inc.
Via
Business Wire
Nuvation Bio Reports First Quarter 2023 Financial Results and Provides Business Update
May 04, 2023
From
Nuvation Bio Inc.
Via
Business Wire
The 7 Worst Stocks to Buy Now
March 18, 2023
With the market reeling from the banking crisis, even hardened gamblers should avoid these worst stocks to buy now.
Via
InvestorPlace
Nuvation Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 15, 2023
From
Nuvation Bio Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023
January 06, 2023
Via
Benzinga
Nuvation Bio Doses First Patient in Phase 1b Combination Study of NUV-868
December 19, 2022
From
Nuvation Bio Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Friday
November 18, 2022
On Friday, 64 companies achieved new lows for the year.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
November 16, 2022
On Wednesday, 70 companies set new 52-week lows.
Via
Benzinga
Nuvation Bio Reports Third Quarter 2022 Financial Results and Provides Business Update
November 03, 2022
From
Nuvation Bio Inc.
Via
Business Wire
Netflix Price Target Cut By This Analyst, Plus Morgan Stanley Predicts $403 For McKesson
August 22, 2022
UBS cut the price target for Coupa Software Incorporated (NASDAQ: COUP) from $84 to $76. Coupa Software shares fell 4.9% to $64.44 in pre-market trading.
Via
Benzinga
Nuvation Bio Reports Second Quarter 2022 Financial Results and Provides Business Update
August 04, 2022
From
Nuvation Bio Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Wednesday
August 03, 2022
Wednesday's session saw 51 companies set new 52-week lows.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022
August 02, 2022
Upgrades
Via
Benzinga
Nuvation Bio Announces Discontinuation of NUV-422 Clinical Development Program
August 01, 2022
From
Nuvation Bio Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Friday
July 22, 2022
During Friday's session, 61 companies made new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
August 01, 2022
On Monday, 92 companies set new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
July 18, 2022
Gainers Biophytis (NASDAQ:BPTS) stock moved upwards by 15.8% to $0.95 during Monday's after-market session. The company's market cap stands at $15.5 million.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
July 28, 2022
On Thursday, 108 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
July 25, 2022
On Monday, 100 companies reached new 52-week lows.
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.